Klotho Suppresses Indoxyl Sulfate-Mediated Apoptosis in Human Kidney Proximal Tubular (HK-2) Cells through Modulating

Chien-Yao Sun1,2,3,4, Yao-Tsung Lin5,6, Yu-Ting Huang3,7

  • 1Department of Geriatric and Gerontology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

ACS Omega
|June 23, 2025
PubMed

Insights

Downregulation of klotho in chronic kidney disease (CKD) impairs cell viability by reducing antioxidant capacity and increasing oxidative stress. Restoring klotho protects against indoxyl sulfate-induced kidney cell damage.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Chronic kidney disease (CKD) is a global health concern.
  • Indoxyl sulfate (IS), a uremic toxin, causes tubulotoxicity and kidney damage.
  • Reduced klotho expression is observed in IS-stimulated kidney cells, but the mechanism is unclear.

Purpose of the Study:

  • To elucidate the role of klotho downregulation in IS-induced kidney cell injury.
  • To investigate the molecular mechanisms linking klotho, oxidative stress, and apoptosis in proximal tubular cells.

Main Methods:

  • Utilized HK-2 cells (a proximal tubular cell line) stimulated with IS.
  • Assessed cell viability, cytotoxicity, and reactive oxygen species (ROS) production.
  • Analyzed the AKT/Nrf2 signaling pathway, antioxidant enzymes (HO-1, NQO1, SOD), mitochondrial function, and apoptosis markers (Bax, Bcl-2, cytochrome c, caspase-3).

Main Results:

  • IS stimulation downregulated klotho, reducing cell viability and increasing cytotoxicity in HK-2 cells.
  • Recombinant klotho restored the AKT/Nrf2 axis, enhancing antioxidant capacity and reducing ROS.
  • Klotho mediated IS-induced mitochondrial dysfunction and apoptosis via the AKT/Nrf2 pathway.

Conclusions:

  • Klotho downregulation in IS-stimulated kidney cells decreases cell viability due to impaired antioxidant defense and mitochondrial dysfunction.
  • The klotho/AKT/Nrf2 axis is crucial in protecting kidney cells against IS-induced oxidative stress and apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K